Koyfin Home > Directory > Health Care > Arena Pharmaceuticals

Arena Pharmaceuticals Price Chart ARNA

Historical daily share price chart and data for Arena Pharmaceuticals since 2000 adjusted for splits and dividends. The latest closing price for Arena Pharmaceuticals as of August 16, 2019 is $55.72.
  • In 2019 the stock opened at $38.36 and closed at $55.72 for a gain of 31% YTD.
  • In 2018 the stock opened at $34.31 and closed at $38.95 for a gain of 12%.
  • In 2017 the stock opened at $14.40 and closed at $33.97 for a gain of 58%.
  • In 2016 the stock opened at $19.10 and closed at $14.20 for a loss of -35%.
View Chart On Koyfin

Arena Pharmaceuticals Summary

Stock Symbol: ARNA

Arena Pharmaceuticals Company Info

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. Its investigational clinical programs include ralinepag (APD811), which is in Phase III trial to treat pulmonary arterial hypertension; etrasimod (APD334) for ulcerative colitis, and Crohn’s disease, as well as for atopic dermatitis and other indications; and Olorinab (APD371), which is in Phase II trial for the treatment of gastrointestinal pain. It is also developing APD418, a calcium-independent myofilament derepressor for the treatment of decompensated heart failure. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Axovant Sciences GmbH; Outpost Medicine LLC; CY Biotech Company Limited; Boehringer Ingelheim International GmbH; Eisai Co., Ltd.; and Eisai Inc. Arena Pharmaceuticals, Inc. was founded in 1997 and is based in San Diego, California.
Market Cap
2.8b
Dividend Yield
0 %
Beta vs SPX
1.52
Short Interest
6.37 %
30D Volatility
48.36
Hedge Fund Held
11.76 %
Competitors

Last 10 Days of ARNA Prices

08/16/2019$55.72
08/15/2019$52.88
08/14/2019$53.65
08/13/2019$53.48
08/12/2019$51.42
08/09/2019$54.10
08/08/2019$56.18
08/07/2019$60.91
08/06/2019$61.93
08/05/2019$60.12